Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
出版年份 2019 全文链接
标题
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
作者
关键词
Gastric cancer, Cancer-associated fibroblasts, Tumor microenvironment, Chemo-resistance, Interleukin-6, Tocilizumab, Jak1-STAT3
出版物
Molecular Cancer
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-03-30
DOI
10.1186/s12943-019-0972-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Differences in the multimodal treatment of gastric cancer: East versus west
- (2017) Ashley Russo et al. JOURNAL OF SURGICAL ONCOLOGY
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas
- (2016) Dakeun Lee et al. Gastric Cancer
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay
- (2015) A. Prat et al. CLINICAL CANCER RESEARCH
- Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
- (2015) C. Duluc et al. EMBO Molecular Medicine
- Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition
- (2015) KYEONG A SO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
- (2015) Hideki Yamaguchi et al. Cancers
- Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
- (2015) Aki Isobe et al. PLoS One
- p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages
- (2014) Julie M. Lowe et al. CANCER RESEARCH
- Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System
- (2014) M. H. Veldman-Jones et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
- (2014) Steven O'Reilly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information
- (2014) Mireia Berdiel-Acer et al. Molecular Oncology
- Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
- (2014) Jeeyun Lee et al. PLoS One
- Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
- (2014) Katsutoshi Ando et al. PLoS One
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Identification of Two Distinct Carcinoma-Associated Fibroblast Subtypes with Differential Tumor-Promoting Abilities in Oral Squamous Cell Carcinoma
- (2013) Daniela Elena Costea et al. CANCER RESEARCH
- Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
- (2013) Pura Muñoz-Cánoves et al. FEBS Journal
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil
- (2013) Zhengdeng Lei et al. GASTROENTEROLOGY
- Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2
- (2013) ALEXANDER ENGSTRÖM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
- (2013) Fiorenza Lotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis
- (2013) Hiroto Kinoshita et al. PLoS One
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
- (2013) Miao-Fen Chen et al. PLoS One
- The role of IL-6 in the radiation response of prostate cancer
- (2013) Chun-Te Wu et al. Radiation Oncology
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
- (2012) Yonghui Wu et al. GUT
- The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
- (2012) Sofia Edin et al. PLoS One
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
- (2011) Toshio Tanaka et al. FEBS LETTERS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas
- (2008) Wen Qiu et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search